We are live on ! Find out more
ARCT icon

Arcturus Therapeutics
ARCT

113 hedge funds and large institutions have $379M invested in Arcturus Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 36 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more call options, than puts

Call options by funds: $6.67M | Put options by funds: $2.99M

16% more capital invested

Capital invested by funds: $328M → $379M (+$51.2M)

2.06% more ownership

Funds ownership: 83.4% → 85.46% (+2.1%)

6% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 36

5% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 20

3% less funds holding

Funds holding: 116 → 113 (-3)

Holders
113
Holders Change
-3
Holders Change %
-2.59%
% of All Funds
1.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
38
Reduced
36
Closed
20
Calls
$6.67M
Puts
$2.99M
Net Calls
+$3.68M
Net Calls Change
+$1.69M

Top Buyers

1
Federated Hermes
Federated Hermes
Pennsylvania
+$11.7M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$11.6M
3
Bank of America
Bank of America
North Carolina
+$10.1M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.79M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.98M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$9.64M
2
State Street
State Street
Massachusetts
-$8.24M
3
AIM
ARK Investment Management
Florida
-$2.95M
4
WP
Woodline Partners
California
-$2.18M
5
IHAM
Integral Health Asset Management
New York
-$1.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
State of Wisconsin Investment Board
51
State of Wisconsin Investment Board
Wisconsin
$386K -$24.9K -1,431 -6%
TI
52
Trexquant Investment
Connecticut
$361K +$371K +21,284 New
NYLIM
53
New York Life Investment Management
New York
$357K +$41.3K +2,371 +13%
JF
54
Jump Financial
Illinois
$347K +$357K +20,478 New
BPC
55
Banque Pictet & Cie
Switzerland
$339K – – –
T. Rowe Price Associates
56
T. Rowe Price Associates
Maryland
$335K +$26.5K +1,522 +8%
SCA
57
Snowden Capital Advisors
New York
$269K – – –
FAM
58
Formidable Asset Management
Ohio
$269K +$3.49K +200 +1%
SAM
59
Shell Asset Management
Netherlands
$269K +$276K +15,855 New
Mitsubishi UFJ Asset Management
60
Mitsubishi UFJ Asset Management
Japan
$264K +$32.7K +1,875 +13%
Ameriprise
61
Ameriprise
Minnesota
$263K +$26.3K +1,510 +11%
New York State Common Retirement Fund
62
New York State Common Retirement Fund
New York
$259K -$157 -9 -0.1%
JAMONY
63
Jacob Asset Management of New York
California
$246K -$112K -6,395 -31%
ACM
64
Aquatic Capital Management
Illinois
$234K +$241K +13,800 New
MIM
65
MetLife Investment Management
New Jersey
$209K – – –
Los Angeles Capital Management
66
Los Angeles Capital Management
California
$209K – – –
DTL
67
Dynamic Technology Lab
Singapore
$207K +$213K +12,193 New
Qube Research & Technologies (QRT)
68
Qube Research & Technologies (QRT)
United Kingdom
$200K +$206K +11,814 New
AIG
69
American International Group
New York
$185K -$697 -40 -0.4%
GCP
70
GSA Capital Partners
United Kingdom
$174K +$179K +10,281 New
Mirae Asset Global Investments
71
Mirae Asset Global Investments
South Korea
$173K +$122 +7 +0.1%
Commonwealth Equity Services
72
Commonwealth Equity Services
Massachusetts
$171K – – –
Legal & General Group
73
Legal & General Group
United Kingdom
$159K +$8.98K +515 +6%
Lazard Asset Management
74
Lazard Asset Management
New York
$140K -$11.6K -666 -7%
VEA
75
Virtus ETF Advisers
New York
$126K -$11.5K -661 -8%
1 2
3
4 5

ARCT Hedge Fund Activity: Q4 2022 in Review

113 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Arcturus Therapeutics (ARCT) for Q4 2022, worth a combined $379M — up 16% from $328M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of ARCT and 19 opened new positions — a net loss of 1 holder — while 36 trimmed existing stakes and 38 added.

The largest buyer was Federated Hermes, adding an estimated $11.7M. The largest seller was Point72 Asset Management, cutting an estimated $9.64M.

  • 113 institutional investors held Arcturus Therapeutics (ARCT) as of Q4 2022, down from 116 in Q3 2022.
  • Funds reported $379M of Arcturus Therapeutics stock for Q4 2022, up 16% quarter-over-quarter.
  • 19 funds opened new Arcturus Therapeutics positions in Q4 2022 and 20 closed out, a net change of -1 holder.
  • The largest Arcturus Therapeutics buyer in Q4 2022 was Federated Hermes, an estimated $11.7M added.
  • The largest Arcturus Therapeutics seller in Q4 2022 was Point72 Asset Management, an estimated $9.64M sold.

Based on aggregated 13F filings for Q4 2022.